Unknown

Dataset Information

0

In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles.


ABSTRACT: Multifunctional mesoporous silica nanoparticles (MSN) with well-integrated multimodality imaging properties have generated increasing research interest in the past decade. However, limited progress has been made in developing MSN-based multimodality imaging agents to image tumors. We describe the successful conjugation of, copper-64 ((64)Cu, t1/2 = 12.7 h), 800CW (a near-infrared fluorescence [NIRF] dye), and TRC105 (a human/murine chimeric IgG1 monoclonal antibody) to the surface of MSN via well-developed surface engineering procedures, resulting in a dual-labeled MSN for in vivo targeted positron emission tomography (PET) imaging/NIRF imaging of the tumor vasculature. Pharmacokinetics and tumor targeting efficacy/specificity in 4T1 murine breast tumor-bearing mice were thoroughly investigated through various in vitro, in vivo, and ex vivo experiments. Dual-labeled MSN is an attractive candidate for future cancer theranostics.

SUBMITTER: Chen F 

PROVIDER: S-EPMC4218929 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4430331 | biostudies-other
| S-EPMC4702985 | biostudies-other
| S-EPMC9389524 | biostudies-literature
| S-EPMC5863326 | biostudies-literature
| S-EPMC4997246 | biostudies-literature
| S-EPMC4262629 | biostudies-literature
| S-EPMC6562767 | biostudies-literature
| S-EPMC4701626 | biostudies-literature
| S-EPMC4452422 | biostudies-literature
| S-EPMC9896485 | biostudies-literature